BioSpace News Archive

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that it has appointed Cheryl L. Cohen and Dr. Garry Neil to the company’s Board of Directors.

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced the appointment of Stephen Gould, Ph.D., as Chief Scientific Officer.

Alpha Tau Medical Ltd. announced that the Israeli Ministry of Environmental Protection has granted the Company an active radioactive license for use and possession of Thorium-228 and Radium-224, radioactive materials which are utilized in the production of the Alpha DaRT sources, in the main manufacturing floor of the Company’s production facility in Jerusalem.

Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria® immunoassay for bladder cancer.

Novanta Inc. announced that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 22nd Annual “New Ideas” Summer Conference on Tuesday, July 12, 2022, which is being held in Greenwich, CT.

A sensor-equipped computer program can accurately identify and count arm movements in people undergoing stroke rehabilitation, a new study shows.

RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced results of the Company’s Annual General Meeting.

Vaxart, Inc. announced that it will host a question-and-answer webcast with investors and analysts on Wednesday, June 22, 2022, at 1:00 p.m. Eastern Time.

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced that in connection with the hiring, announced on June 13, 2022, of Keith A. Goldan as Chief Financial Officer, Mr. Goldan received an inducement award to purchase up to 230,000 shares of common stock.

Lyndra Therapeutics announced that President and Chief Operations Officer Jess Ballinger has been named to the National Small Business Association Leadership Council, joining other advocates from across the country as they work to promote the interests of small business to policymakers in Washington, D.C.